Logo

American Heart Association

  20
  0


Final ID: Su2031

Identification of High Risk Cases in Coronary Artery Calcium (CAC) Scans based on CAC Score and AI-driven Cardiometabolic Biomarkers: An AI-CVD Study within the Multi-Ethnic Study of Atherosclerosis (MESA)

Abstract Body (Do not enter title and authors here): Introduction: Coronary artery calcium (CAC) scans contain more information than currently reported. The AI-CVD initiative aims to extract actionable opportunististic infomration from a CAC scan to maximize its predictive value beyond the CAC score. We previously reported new AI-CVD algorithms applied to CAC scans for opportunistic measurement of bone mineral density (BMD), cardiac chamber volumes, left ventricular mass, liver steatosis, emphysema and other imaging biomarkers. In this report, we investigate the incremental value of these biomarkers on top of the CAC score for prediction of incident all cardiovascular disease (CVD) events.

Methods: We applied AI-CVD to CAC scans from 5798 asymptomatic individuals (52% female, age 62±10 years) in the Multi-Ethnic Study of Atherosclerosis. Liver fat was estimated as the liver attenuation index (LAI) using the percentage of voxels below 40 HU. Phantomless BMD for three consecutive thoracic vertebrae (T2-T4) was calculated using the mean HU. Emphysema was estimated using the percentage of voxels within the entire lung in the field of view below -950 HU. We used Kaplan–Meier cumulative incidence curves to evaluate the incremental prognostic value of opportunistically derived biomarkers beyond the Agatston CAC score, using the highest quartile of risk per predictor.

Results: A total of 1173 CVD accrued over 19 years follow-up (median [IQR]: 17.7 [12.9-18.5] years). The top quartile of CAC, LAI, and emphysema were defined as >90, >50.4% voxels below 40 HU, > 4.1% below -950 HU, respectively. The bottom quartile of BMD was defined as <130.1 mg/cc. Individuals in the highest risk quartile of all 4 measures (n=44) experienced 69.0% (95% CI: 57.3%-80.1%) incidence of all CVD events. While individuals with a high Agatston score alone experienced 47.9% (44.6%-51.4%) incidence of CVD events over 19 years. Both low BMD and high LAI revealed incremental CVD risk on top of high CAC scores, while high emphysema measurements did not.

Conclusion: Applying AI to CAC scans can extract opportunistic incremental risk information for early detection of patients at risk of CVD events. The clinical utility of incorporating LAI, BMD, and emphysema and other opportunistic findings in CAC scans as part of the AI-CVD initiative to improve CVD risk prediction warrants further investigations.
  • Naghavi, Morteza  ( HeartLung Technologies , Houston , Texas , United States )
  • Wong, Nathan  ( University of California, Irvine , Irvine , California , United States )
  • Kloner, Robert  ( Huntington Medical Research Inst. , Pasadena , California , United States )
  • Atlas, Kyle  ( HeartLung Technologies , Houston , Texas , United States )
  • Zhang, Chenyu  ( HeartLung Technologies , Houston , Texas , United States )
  • Reeves, Anthony  ( Cornell University , Ithaca , New York , United States )
  • Branch, Andrea  ( Mount Sinai Hospital , New York , New York , United States )
  • Wasserthal, Jakob  ( University Basel , Basel , Switzerland )
  • Atlas, Thomas  ( Tustin Teleradiology , Tustin , California , United States )
  • Yankelevitz, David  ( Mount Sinai Hospital , New York , New York , United States )
  • Henschke, Claudia  ( Mount Sinai Hospital , New York , New York , United States )
  • Author Disclosures:
    Morteza Naghavi: DO have relevant financial relationships ; Ownership Interest:HeartLung.AI:Active (exists now) | Nathan Wong: DO have relevant financial relationships ; Research Funding (PI or named investigator):Amgen, Novartis, Ionis:Active (exists now) ; Consultant:Ionis:Past (completed) ; Speaker:Novartis:Past (completed) ; Consultant:Heart Lung, Amgen, Novartis:Active (exists now) ; Research Funding (PI or named investigator):Novo Nordisk, Regeneron:Past (completed) | Robert Kloner: DO have relevant financial relationships ; Consultant:Hoskinson Health Clinic:Active (exists now) | Kyle Atlas: No Answer | Chenyu Zhang: DO have relevant financial relationships ; Employee:HeartLung Corporation:Active (exists now) ; Individual Stocks/Stock Options:HeartLung Corporation:Active (exists now) | Anthony Reeves: DO have relevant financial relationships ; Individual Stocks/Stock Options:HeartLung Technologies:Active (exists now) | Andrea Branch: DO NOT have relevant financial relationships | Jakob Wasserthal: DO have relevant financial relationships ; Consultant:HeartLungAi:Active (exists now) | Thomas Atlas: No Answer | David Yankelevitz: DO have relevant financial relationships ; Royalties/Patent Beneficiary:General Electric:Active (exists now) ; Individual Stocks/Stock Options:Accumetra:Active (exists now) ; Advisor:Lunglife AI:Active (exists now) ; Advisor:Carestream:Active (exists now) ; Advisor:Median Technology:Active (exists now) ; Individual Stocks/Stock Options:HeartLung:Active (exists now) | Claudia Henschke: No Answer
Meeting Info:

Scientific Sessions 2025

2025

New Orleans, Louisiana

Session Info:

Redefining Cardiovascular Risk and Care: Integrating AI, Imaging, Biomarkers, and Social Contexts

Sunday, 11/09/2025 , 03:15PM - 04:15PM

Abstract Poster Board Session

More abstracts on this topic:
AI-enabled bone mineral density (AutoBMD AI) measurement in coronary artery calcium (CAC) scans associated with high CAC score independently of conventional risk factors: Multi-Ethnic Study of Atherosclerosis (MESA)

Naghavi Morteza, Atlas Kyle, Zhang Chenyu, Reeves Anthony, Atlas Thomas, Henschke Claudia, Yankelevitz David, Roy Sion, Budoff Matthew

Admission Cell-free DNA Predicts Cardiogenic Shock Progression and In-Hospital Mortality

Park Ashley, Kong Hyesik, Andargie Temesgen, Jang Moon, Solomon Michael, Brusca Samuel, Barnett Christopher, Obrien Connor, Agbor-enoh Sean

More abstracts from these authors:
AI-driven Aortic Valve Calcification Measurement in Coronary Artery Calcium Scan Detects Aortic Stenosis Comparably to Human Experts: An AI-CVD Study within the Framingham Heart Study

Naghavi Morteza, Atlas Kyle, Zhang Chenyu, Reeves Anthony, Atlas Thomas, Wasserthal Jakob, Yankelevitz David, Henschke Claudia, Wong Nathan

AI-enabled Ascending Aorta and Pulmonary Trunk Volumetry in Coronary Artery Calcium Scans for Heart Failure Prediction: An AI-CVD Study within the Multi-Ethnic Study of Atherosclerosis (MESA)

Naghavi Morteza, Atlas Kyle, Zhang Chenyu, Reeves Anthony, Atlas Thomas, Wong Nathan, Wasserthal Jakob, Henschke Claudia, Yankelevitz David

You have to be authorized to contact abstract author. Please, Login
Not Available